AU681362B2 - OP-3-induced morphogenesis - Google Patents
OP-3-induced morphogenesisInfo
- Publication number
- AU681362B2 AU681362B2 AU55900/94A AU5590094A AU681362B2 AU 681362 B2 AU681362 B2 AU 681362B2 AU 55900/94 A AU55900/94 A AU 55900/94A AU 5590094 A AU5590094 A AU 5590094A AU 681362 B2 AU681362 B2 AU 681362B2
- Authority
- AU
- Australia
- Prior art keywords
- amino acid
- seq
- species
- tissue
- leu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/50—Preparations specially adapted for dental root treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97109192A | 1992-11-03 | 1992-11-03 | |
US971091 | 1992-11-03 | ||
US2933593A | 1993-03-04 | 1993-03-04 | |
US4051093A | 1993-03-31 | 1993-03-31 | |
PCT/US1993/010520 WO1994010203A2 (en) | 1992-11-03 | 1993-11-02 | Op-3-induced morphogenesis |
Publications (2)
Publication Number | Publication Date |
---|---|
AU5590094A AU5590094A (en) | 1994-05-24 |
AU681362B2 true AU681362B2 (en) | 1997-08-28 |
Family
ID=27363460
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU55900/94A Ceased AU681362B2 (en) | 1992-11-03 | 1993-11-02 | OP-3-induced morphogenesis |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0672064A1 (ja) |
JP (1) | JPH08503198A (ja) |
AU (1) | AU681362B2 (ja) |
CA (1) | CA2147598A1 (ja) |
WO (1) | WO1994010203A2 (ja) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5972703A (en) * | 1994-08-12 | 1999-10-26 | The Regents Of The University Of Michigan | Bone precursor cells: compositions and methods |
US6498142B1 (en) | 1996-05-06 | 2002-12-24 | Curis, Inc. | Morphogen treatment for chronic renal failure |
EP1350525A3 (en) † | 1997-02-07 | 2003-12-10 | Stryker Corporation | Matrix-free osteogenic devices, implants and methods thereof |
US7041641B2 (en) | 1997-03-20 | 2006-05-09 | Stryker Corporation | Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects |
US20010016646A1 (en) | 1998-03-20 | 2001-08-23 | David C. Rueger | Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects |
DE69826854T2 (de) | 1997-05-05 | 2006-02-02 | Curis, Inc., Cambridge | Therapien zur behandlung von akutem nierenversagen |
US20030032586A1 (en) * | 1997-05-15 | 2003-02-13 | David C. Rueger | Compositions for morphogen-induced osteogenesis |
EP1988395A1 (en) | 1997-05-30 | 2008-11-05 | Curis, Inc. | Methods for evaluating tissue morphogenesis and morphogenic activity |
US7147839B2 (en) | 1998-05-29 | 2006-12-12 | Curis, Inc. | Methods for evaluating tissue morphogenesis and activity |
US8372419B2 (en) | 2004-03-10 | 2013-02-12 | Scil Technology Gmbh | Coated implants, their manufacturing and use thereof |
EP1763362B1 (en) | 2004-05-25 | 2011-07-06 | Stryker Corporation | Use of op-1 for treating cartilage defects |
JP5362554B2 (ja) | 2006-05-17 | 2013-12-11 | ストライカー コーポレイション | 軟骨の欠損を処置するための可溶性形態形成タンパク質の使用 |
AU2007234612B2 (en) | 2006-12-14 | 2013-06-27 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein stabilization formulations |
EP2120859B1 (en) | 2006-12-21 | 2013-11-20 | Stryker Corporation | Sustained-release formulations comprising bmp-7 crystals |
US7678764B2 (en) | 2007-06-29 | 2010-03-16 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein formulations for use at elevated temperatures |
EP2187932B1 (en) | 2007-08-07 | 2015-01-28 | DePuy Synthes Products, LLC | Protein formulations comprising gdf-5 in aqueous acidic solution |
US8741840B2 (en) | 2008-02-13 | 2014-06-03 | Washington University | BMP-7 for use in treating neointimal hyperplasia |
WO2009129101A1 (en) | 2008-04-14 | 2009-10-22 | Advanced Technologies And Regenerative Medicine, Llc | Liquid buffered gdf-5 formulations |
SG173634A1 (en) | 2009-02-12 | 2011-09-29 | Stryker Corp | COMPOSITIONS AND METHODS FOR MINIMALLY-INVASIVE SYSTEMIC DELIVERY OF PROTEINS INCLUDING TGF-ß SUPERFAMILY MEMBERS |
JP5819733B2 (ja) | 2009-02-12 | 2015-11-24 | ストライカー コーポレイションStryker Corporation | 障害および疾患に対する全身治療のためのTGF−βスーパーファミリーメンバー含有タンパク質の末梢投与 |
US20120148539A1 (en) | 2009-03-24 | 2012-06-14 | Moulay Hicham Alaoui-Ismaili | Methods and Compositions for Tissue Engineering |
WO2011031856A1 (en) | 2009-09-09 | 2011-03-17 | Stryker Corporation | Bmp -7 for use in treating pain induced by injuries and diseases of an articular joint |
EP2352750B1 (en) | 2009-09-17 | 2012-06-13 | Stryker Corporation | Buffers for controlling the ph of bone morphogenetic proteins |
CA2785038A1 (en) | 2009-12-22 | 2011-07-21 | Stryker Corporation | Bmp-7 variants with reduced immunogenicity |
ES2609352T3 (es) | 2011-12-30 | 2017-04-19 | Innomed S.A. | Combinación de factores de crecimiento, citoquinas, factores antibacterianos/antivíricos, factores estimulantes de células madre, proteínas del complemento C3a/C4a, inmunoglobulinas y factores quimiotácticos |
ITMI20112437A1 (it) * | 2011-12-30 | 2013-07-01 | Bionest Ltd | Uso di citochine, fattori di crescita e fattori antibatterici come materiale di sottofondo di cavita' per la terapia della carie penetrante dei denti e dell'infiammazione pulpare |
WO2013098331A1 (en) * | 2011-12-30 | 2013-07-04 | Bionest Ltd. | Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins c3a/c4a, and chemotactic factors |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU678380B2 (en) * | 1992-07-31 | 1997-05-29 | Stryker Corporation | Morphogenic protein soluble complex and composition thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE01201555T1 (de) * | 1988-04-08 | 2004-07-08 | Stryker Corp., Kalamazoo | Biosynthetische osteogene Proteine und solche enthaltende osteogene Einrichtungen |
US5106626A (en) * | 1988-10-11 | 1992-04-21 | International Genetic Engineering, Inc. | Osteogenic factors |
US5011961A (en) * | 1990-06-13 | 1991-04-30 | Dow Corning Limited | Method of making organosilbutadiyne polymers |
ES2161693T3 (es) * | 1991-03-11 | 2001-12-16 | Curis Inc | Morfogenesis inducida por proteinas. |
EP1637156A1 (en) * | 1991-08-30 | 2006-03-22 | Curis, Inc. | Systemic administration of osteogenic proteins in the treatment of metabolic bone diseases |
-
1993
- 1993-11-02 AU AU55900/94A patent/AU681362B2/en not_active Ceased
- 1993-11-02 JP JP6511392A patent/JPH08503198A/ja active Pending
- 1993-11-02 WO PCT/US1993/010520 patent/WO1994010203A2/en not_active Application Discontinuation
- 1993-11-02 CA CA002147598A patent/CA2147598A1/en not_active Abandoned
- 1993-11-02 EP EP94901244A patent/EP0672064A1/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU678380B2 (en) * | 1992-07-31 | 1997-05-29 | Stryker Corporation | Morphogenic protein soluble complex and composition thereof |
Also Published As
Publication number | Publication date |
---|---|
CA2147598A1 (en) | 1994-05-11 |
AU5590094A (en) | 1994-05-24 |
WO1994010203A3 (en) | 1994-08-18 |
JPH08503198A (ja) | 1996-04-09 |
WO1994010203A2 (en) | 1994-05-11 |
EP0672064A1 (en) | 1995-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU681362B2 (en) | OP-3-induced morphogenesis | |
AU660019B2 (en) | Protein-induced morphogenesis | |
US6333312B1 (en) | Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases | |
US6800603B2 (en) | Morphogen-induced neural cell adhesion | |
US6153583A (en) | OP-3 induced morphogenesis | |
AU681594B2 (en) | Morphogen-induced nerve regeneration and repair | |
EP0646022A1 (en) | Prosthetic devices having enhanced osteogenic properties | |
US6495513B1 (en) | Morphogen-enhanced survival and repair of neural cells | |
US6949505B1 (en) | Morphogen-induced dendritic growth | |
WO1993005751A2 (en) | Osteogenic proteins in the treatment of bone deseases | |
US5652118A (en) | Nucleic acid encoding a novel morphogenic protein, OP-3 | |
US20030105004A1 (en) | Novel morphogenic protein compositions of matter | |
EP0652953A1 (en) | Morphogenic protein soluble complex and composition thereof | |
AU5162393A (en) | Morphogen-induced liver regeneration | |
AU2862492A (en) | Morphogenic protein screening method | |
WO1994006399A1 (en) | Morphogen-induced periodontal tissue regeneration | |
US6211146B1 (en) | 60A protein-induced morphogenesis | |
EP0680334A1 (en) | Morphogen treatment of gastrointestinal ulcers | |
US20030224979A1 (en) | Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases | |
AU670558C (en) | Osteogenic proteins in the treatment of bone diseases | |
AU670334B2 (en) | Morphogen-induced periodontal tissue regeneration | |
WO1994006447A2 (en) | 60a protein-induced morphogenesis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |